Lipoprotein (a) in the Interstitial Fluid and Serum of Patients with Chronic Renal Failure and Matched Controls

1996 ◽  
Vol 91 (s35) ◽  
pp. 11P-12P
Author(s):  
G.N.I. Wood ◽  
D. Bhatnagar ◽  
M.I. MacKness ◽  
W A Herd ◽  
C.D. Short ◽  
...  
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Interstitial Fluid ◽  
Lipoprotein A

Lipoprotein(a) in Diabetic Patients with and Without Chronic Renal Failure

Diabetes Care ◽  
1992 ◽  
Vol 15 (8) ◽  
pp. 976-979 ◽  
Author(s):  
P. J. Guillausseau ◽  
J. Peynet ◽  
P. Chanson ◽  
A. Legrand ◽  
J. J. Altman ◽  
...  
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Diabetic Patients ◽  
Lipoprotein A

scholarly journals Lipoprotein (a) in Chronic Renal Failure Patients Undergoing Hemodialysis: Does It Have an Independent Role in the Development of Further Cardiovascular Complications?

Nephron ◽  
1993 ◽  
Vol 65 (4) ◽  
pp. 644-645 ◽  
Author(s):  
Jorge del Cura ◽  
Antonio Gil-Paraiso ◽  
Luis Borque ◽  
Maria-Eugenia Carazo ◽  
Carlos Maside ◽  
...  
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Cardiovascular Complications ◽  
Lipoprotein A

scholarly journals Increased Lipoprotein (a) and Its Relationships with Other Parameters of Lipoprotein Metabolism in Chronic Renal Failure Treated by Hemodialysis.

1997 ◽  
Vol 38 (1) ◽  
pp. 83-89 ◽  
Author(s):  
M. Ramazan YIGITOGLU ◽  
M. Fevzi POLAT ◽  
Fatih AKÇAY ◽  
Zeki ARI ◽  
B. Sami UYANIK ◽  
...  
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Lipoprotein Metabolism ◽  
Lipoprotein A

scholarly journals Significance of lipoprotein(a) in diabetic chronic renal failure

2017 ◽  
Vol 5 (9) ◽  
pp. 3856
Author(s):  
Vasanthan M.
Keyword(s):  
Diabetes Mellitus ◽  
Metabolic Disease ◽  
Renal Failure ◽  
Chronic Renal Failure ◽  
The Other ◽  
Lipoprotein A ◽  
Positive Correlation ◽  
Duration Of Diabetes

Background: Diabetes mellitus, is a metabolic disease with an alarming prevalence worldwide. When uncontrolled, this can result in diseases such as chronic renal failure by various atherogenic factors including lipoprotein(a). Aim was to estimate the level of lipoprotein(a) in diabetic chronic renal failure patients and to correlate with healthy controls.Methods: 30 non-diabetic subjects and 30 diabetic CRF patients were included in the study. Lipoprotein(a) was estimated by immunoturbidimetric method and the other parameters by their respective methods in biochemistry auto-analyzer.Results: It was found from the study that there is a positive correlation of lipoprotein(a) levels with the duration of diabetes and was progressive with the diabetic complications.Conclusions: Lipoprotein(a) is responsible for atherogenic events in CRF patients.

scholarly journals Low-Molecular-Weight Heparin and Lipoprotein(a) in Patients with Chronic Renal Failure

Nephron ◽  
1997 ◽  
Vol 76 (1) ◽  
pp. 123-124 ◽  
Author(s):  
Andrea Sagripanti ◽  
Vincenzo Cozza ◽  
Giuliano Barsotti
Keyword(s):  
Molecular Weight ◽  
Renal Failure ◽  
Chronic Renal Failure ◽  
Low Molecular Weight Heparin ◽  
Low Molecular Weight ◽  
Lipoprotein A

Lipoprotein (a) in Chronic Renal Failure: Effect of Maintenance Hemodialysis

2003 ◽  
Vol 7 (4) ◽  
pp. 326-331 ◽  
Author(s):  
Om Prakash Kalra ◽  
Ambar Khaira ◽  
Jasvinder Kaur Gambhir ◽  
Sunil Agarwal ◽  
Satish Kumar Bhargava
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Maintenance Hemodialysis ◽  
Lipoprotein A

Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failure

1996 ◽  
Vol 11 (11) ◽  
pp. 2237-2243 ◽  
Author(s):  
O. Samuelsson ◽  
P.-O. Attman ◽  
C. Knight-Gibson ◽  
R. Larsson ◽  
H. Mulec ◽  
...  
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Plasma Levels ◽  
Lipoprotein A

scholarly journals Lipoprotein(a) in Chronic Renal Failure

2009 ◽  
Vol 28 (2) ◽  
pp. 82-88
Author(s):  
Velibor Čabarkapa ◽  
Mirjana Đerić ◽  
Zoran Stošić ◽  
Vladimir Sakač ◽  
Sunčica Kojić-Damjanov ◽  
...  
Keyword(s):  
Renal Failure ◽  
Renal Function ◽  
Chronic Renal Failure ◽  
Serum Concentration ◽  
Elevated Serum ◽  
Serum Levels ◽  
Chronic Hemodialysis ◽  
Control Group ◽  
Elevated Concentration ◽  
Lipoprotein A

Lipoprotein(a) in Chronic Renal Failure Cardiovascular diseases are the leading cause of mortality in patients with chronic renal failure. Among the parameters contributing to cardiovascular disease development is the elevated serum concentration of lipoprotein(a) diagnosed in these patients, especially in the terminal stage of CRF. However, an elevated concentration of lipoprotein(a) could influence the renal failure progression. The objective of this study is to examine the lipoprotein(a) serum levels in chronic renal failure, and to establish the relation between the stage of renal function preservation and the level of this lipoprotein. In this study 127 subjects were included, divided into three groups. The first group contained 42 subjects (15 females and 27 males) in different CRF stages, the second group contained 32 subjects (7 females and 25 males) on a chronic hemodialysis program, and the control group contained 53 subjects (22 females and 31 males) with regular renal function. The results obtained point to significantly higher frequency of hyper-Lp(a) lipoproteinaemia in dialysed patients compared to the control group, as well as significantly higher Lp(a) values in both groups of patients compared to the control group. It can be concluded that for the risk assessment of premature atherosclerotic changes, but also renal failure progression in patients with CRF, determination of the Lp(a) serum concentration is recommendable.

Sign in / Sign up

Export Citation Format

Share Document